For instance, BRCA1/BRCA2 and CDKN2A were positive in up to 17% and 5% of patients with a family history of PC, respectively; however, these observations were seen in a fraction of patients, and further studies are needed to evaluate their contribution [100,101,102,103]. This evidence concerns the gene CDKN2A and pachyonychia congenita.